Hyundai Bioland Co Ltd - Company Profile and SWOT Analysis
SummaryHyundai Bioland Co Ltd - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Hyundai Bioland Co Ltd (Hyundai Bioland), a subsidiary of Hyundai Department Store Group Co Ltd, is a manufacturer of raw materials for cosmetics, health food, and active pharmaceutical ingredients (API) and develops medical-grade biomaterial technology. The company's product portfolio comprises of cosmetics ingredients for anti-aging, whitening, moisturizing, skin protection, moisturizing, hair and body care, and sheet masks. It also offers health functional food ingredients including individually licensed nutraceuticals, notified nutraceuticals, general food ingredients, biomedical material, and active pharmaceutical ingredients. Hyundai Bioland operates its manufacturing plants in Cheonan, Asan, Ochang, Osong, Haimen and Jeju cities of South Korea. Hyundai Bioland is headquartered in Cheonan, Chungbuk, South Korea.
Scope
- Detailed information on Hyundai Bioland Co Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Hyundai Bioland Co Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Hyundai Bioland Co Ltd including a breakdown and examination of key business segments
- Intelligence on Hyundai Bioland Co Ltd's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Hyundai Bioland Co Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons To Buy
- Gain understanding of Hyundai Bioland Co Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Hyundai Bioland Co Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Hyundai Bioland Co Ltd's business structure, strategy and prospects.
Myungmoon Pharmaceutical Company Limited. MyungMoon Pharm. Co., Ltd. is a Korea-based company mainly engaged in the manufacture of pharmaceuticals. Its products include ethical (ETC) drugs and over the counter (OTC) drugs. Its ETC drugs include anesthetic agents, digestive system drugs, rheumatoid arthritis remedies, central nervous system drugs, circulatory drugs, anti-depressant agents, anti-diabetic agents, antibiotics, hormone agents, narcotics and drugs for dermatology systems. Its OTC drugs include antinauseant agents, hepatic agents, immunologic agents, antidiarrheal agents, skin external preparations, antiallergic agents, muscle relaxants, cold drugs and parasiticides. The Company is also involved in the operation golf courses. January 2, 2012, the Company completed the merger with its wholly owned subsidiary.
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.